Back
AbbVie Vs. ePlus Industry Stock Comparison
Sell
31
ABBV
AbbVie
Last Price:
169.64
Seasonality Move:
4.77%
Sell
29
PLUS
ePlus
Last Price:
80.50
Seasonality Move:
20.86%
Sell
31
AbbVie (ABBV)
is a Sell
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $169.63. The Score for ABBV is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- ABBV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
ePlus (PLUS)
is a Sell
Is ePlus a Buy, Sell or Hold?
- The current ePlus [PLUS] share price is $80.48. The Score for PLUS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- PLUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABBV Stock Price Chart
PLUS Stock Price Chart
ABBV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.44 | Sell |
Relative Strength Index (14 RSI): | 25.12 | Sell |
Chaikin Money Flow: | -2270550 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (180.81 - 201.03) | Sell |
Bollinger Bands (100): | (176.73 - 198.57) | Sell |
PLUS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.29 | Sell |
Relative Strength Index (14 RSI): | 29.13 | Sell |
Chaikin Money Flow: | -131262 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (89.57 - 100.91) | Sell |
Bollinger Bands (100): | (81.36 - 98.26) | Sell |
ABBV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 186.05 | Sell |
20-day SMA: | 190.32 | Sell |
50-day SMA: | 192.69 | Sell |
200-day SMA: | 178.83 | Sell |
8-day EMA: | 181.35 | Sell |
20-day EMA: | 188.28 | Sell |
50-day EMA: | 190.36 | Sell |
200-day EMA: | 179.16 | Sell |
PLUS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 92.25 | Sell |
20-day SMA: | 94.05 | Sell |
50-day SMA: | 95.08 | Sell |
200-day SMA: | 83.6 | Sell |
8-day EMA: | 89.64 | Sell |
20-day EMA: | 92.96 | Sell |
50-day EMA: | 93.52 | Sell |
200-day EMA: | 84.4 | Sell |
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $1.17 per share.
ePlus Earnings Growth & PLUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and a decrease next year of $0.07 per share.
AbbVie Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ePlus Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |